not exhibit similarity to other known proteins, the neuconfer specificity to the Sema IV repulsive response, ropilin-1 extracellular domain is composed of two N-terand these domains of neuropilin-1 are necessary and minal domains similar to complement-binding domains sufficient for binding of the Sema III semaphorin (sema) (CUB domains, also called a1 and a2), two coagulation domain. The coagulation factor domains alone are necfactor (V/VIII) domains (also called b1 and b2), and one essary and sufficient for binding of the Sema III immu-
of expression, consistent with a model in which this
The extent of repulsion was quantified by measuring the length of axons extending proximal (P) and distal (D) ligand-receptor complex participates in the development of axonal trajectories of postganglionic symparelative to the COS cell aggregate. These data are presented as P/D values (Figure 1). As previously described thetic neurons and other neuropilin-2-expressing neuronal populations. Lastly, we have determined that the (He and Tessier-Lavigne, 1997; Kolodkin et al., 1997), NGF-dependent DRG neurons were strongly repelled by neuropilin-1 CUB and coagulation factor domains, but not the MAM domain, mediate semaphorin binding, while Sema III, and antibodies directed against neuropilin-1 significantly attenuated this repulsive effect (data not multiple extracellular domains appear to contribute to neuropilin homo-and heteromultimerization. Therefore, shown). In sharp contrast, NGF-dependent DRG neurons were not repelled by Sema IV. Thus, although Sema neuropilin-1 and neuropilin-2 are functional receptors for distinct secreted semaphorins. We propose a model IV can bind to neuropilin-1, it is not repulsive for neuropilin-1-expressing DRG neurons. to explain functional specificity of semaphorin-neuropilin interactions.
Results

Neuropilin-1 and Neuropilin-2 Are Expressed in Sympathetic Neurons
In situ hybridization experiments have indicated that Sema III, but Not Sema IV, Repels E15 DRG Neurons neuropilin-2 is expressed in several populations of neurons, and any or all of these neuropilin-2-expressing Both Sema III and Sema IV bind to neuropilin-1, which is expressed in E15 DRG neurons. We therefore asked neurons may be responsive to Sema IV. To identify populations of neurons that express neuropilin-2 protein, whether neuropilin-1 can function as a receptor for both of these secreted semaphorins in DRG neurons. For rabbit polyclonal antibodies directed against the MAM domain of rat neuropilin-2 were generated and characthese experiments, an in vitro paradigm was used in which aggregates of COS cells secreting either Sema terized. Previously, antibodies specific for neuropilin-1 had been generated and characterized (Kolodkin et al., III or Sema IV were cocultured with nerve growth factor-(NGF-) dependent sensory neurons emanating from a 1997). Anti-neuropilin-1 (␣-Npn-1) and anti-neuropilin-2 (␣-Npn-2) antibodies do not cross-react (Figure 2A ), and DRG explant taken from E15 rat embryos. After 2 days of growth, the repulsive activity of the semaphorins toward ␣-Npn-2 detected a single band on immunoblots of tissue extracts of superior cervical ganglia (SCG) taken neuropilin-1-expressing DRG neurons was assessed. not cross-react, and both proteins are expressed in developing postganglionic sympathetic neurons.
Since Sema IV repels axons of neuropilin-2-expressing sympathetic neurons, but not axons from neuropilinNeuropilin-2 Is Necessary for the Chemorepulsive Activity of Sema IV, but Not Sema III, 1-expressing DRG neurons, we hypothesized that neuropilin-2 is the functional receptor for Sema IV. Likewise, Toward Sympathetic Neurons Since neuropilin-2 binds to Sema IV with high affinity, since neuropilin-2 does not bind Sema III with high affinity, it is unlikely that neuropilin-2 is a functional receptor and since neuropilin-2 protein is expressed in sympathetic neurons within the SCG (Figure 2C ), we next tested for Sema III in sympathetic neurons. To directly test these ideas, ␣-Npn-1 and ␣-Npn-2 were used in SCG whether Sema IV can repel the axons of sympathetic neurons. To assess whether Sema III and/or Sema IV coculture experiments to assess the requirement for these neuropilins during Sema III-and Sema IV-medirepel the axons of sympathetic neurons, we used an assay in which SCG explants taken from E18 rat emated repulsive guidance of sympathetic neurons. AntiNpn-1, but not ␣-Npn-2, blocked the repulsive effects bryos were cocultured with cell aggregates secreting either Sema III or Sema IV. Both Sema III and Sema of Sema III toward SCG neurons (Figure 3) . These results are consistent with the previous studies that demon-IV were found to be potent repellents of the axons of sympathetic neurons ( Figure 3A) . strated that neuropilin-1 is a receptor for Sema III in NGF-dependent DRG neurons. In contrast, ␣-Npn-2 sigAfter 2 days of growth, the cultures were visualized under phase contrast and fluorescence microscopy to nificantly attenuated repulsion of sympathetic neuron axons by Sema IV (Figure 3) . A similar inhibitory effect identify axons of GFP-positive sensory neurons emanating from the DRG explants. Neurons cotransfected with on Sema IV-mediated repulsion of sympathetic neurons was seen with two different antibodies directed against expression vectors encoding GFP and neuropilin-2 expressed both proteins (data not shown). As expected, the neuropilin-2 MAM domain. Moreover, ␣-Npn-1 did not block the repulsive effects of Sema IV toward SCG axons of untransfected DRG neurons as well as those expressing GFP alone were not repelled by Sema IV neurons ( Figures 3A and 3B) . Preimmune IgG at equal concentrations had no effect on Sema IV repulsive activ-(data not shown) and neither were axons of DRG neurons transfected with neuropilin-1 ( Figures 4A and 4D ). In ity (data not shown). Together with the observation that Sema IV binds neuropilin-2 with high affinity, these redramatic contrast, 293T cells expressing Sema IV potently repelled the axons of DRG neurons cotransfected sults show that neuropilin-2, but not neuropilin-1, is required for the repulsive activity of Sema IV.
with GFP and neuropilin-2 expression vectors ( Figures  4B and 4D ). These results indicate that neuropilin-2 can mediate the repulsive effects of Sema IV. Taken together Neuropilin-2 Mediates the Repulsive with the observations that Sema IV binds to neuropilin-2 Effects of Sema IV with high affinity and that neuropilin-2 is necessary for If neuropilin-2 is a functional receptor for Sema IV, then the repulsive effects of Sema IV toward axons on sympaexpression of neuropilin-2 in neurons that normally do thetic neurons (Figure 3) , we conclude that neuropilin-2 not express this neuropilin should confer upon these is a functional receptor for the secreted semaphorin neurons the ability to respond to Sema IV. As mentioned Sema IV. above, NGF-dependent DRG sensory neurons do not express neuropilin-2, nor do they respond to Sema IV. We utilized particle-mediated gene transfer to introduce Sema IV and Neuropilin-2 Are Expressed in Complementary Fashion an expression vector encoding the neuropilin-2(a17) isoform along with an expression vector encoding green in the Rat Embryo Since neuropilin-2 is a functional receptor for Sema IV, fluorescent protein (GFP) into NGF-dependent sensory neurons in explants of DRG. Then, the transfected DRG semaIV and neuropilin-2 should be expressed in a complementary fashion during neurodevelopment. Expresexplants were cocultured with aggregates of Sema IVsecreting 293T cells and grown in a collagen gel matrix.
sion of semaIV was determined by in situ hybridization to rat embryos and in several instances nicely fulfills this prediction. Below, we describe neuronal and nonneuronal patterns of expression of semaIV.
Olfactory System
In the E18 rat olfactory system, semaIV is strongly expressed in the cells dispersed throughout the main olfactory epithelium (OE) (Figures 5A and 6D) , with somewhat stronger expression observed in the basal OE. In the nasal cavity, expression of semaIV is found in the respiratory epithelium, forming a continuum with the more dispersed expression in the more dorsally located OE. The vomeronasal organ (VNO) displays strong semaIV expression on the concave aspect of the sensory epithelium ( Figure 5A ). In contrast, neuropilin-2 is expressed in the basal V2R neurons of the VNO ( Figure  5B ) (Chen et al., 1997) , suggesting that Sema IV may act as a chemorepellent to direct the initial trajectories of these VNO neurons. In the embryonic olfactory bulb (OB), moderate semaIV expression is observed in the lateral mitral cell layer, increasing slightly toward the medial portion of the OB ( Figure 5A ). No semaIV expression is observed in the accessory olfactory bulb. Again, this is in contrast to neuropilin-2 expression in the main OB, which is found in an increasing medial-to-lateral In the thalamus at E18, semaIV is expressed in the thala- IV on SCG neurons, whereas function-blocking anti-neuGinty, 1997). semaIV and neuropilin-2 are often expressed in patterns that suggest that Sema IV serves ropilin-1 antibodies did not. Moreover, expression of neuropilin-2 in NGF-dependent DRG neurons conferred to define regions that are repulsive to specific classes of axons during pathfinding in neurodevelopment. upon those neurons the ability to respond to Sema IV. These results, in addition to establishing that Sema IV In the developing olfactory system, semaIV is expressed in regions apical to the VNR neurons of the VNO. can function as a neuronal chemorepellent, suggest that Sema IV acts through its interactions with neuropilin-2 Equally strong expression of neuropilin-2 is observed in the V2R neurons of the basal VNO. The V2R neurons and not neuropilin-1, even though Sema IV is able to bind to neuropilin-1 with high affinity. Whether neuropilin-2 initially project basally into the accessory olfactory nerve, away from the region of semaIV expression in serves as a functional receptor for other semaphorins remains to be determined. Another candidate ligand for the VNO (reviewed by Bargmann, 1997), commensurate with the idea that Sema IV serves to direct the initial neuropilin-2 is Sema E. SCG neurons are repelled by Sema E, and Sema E can bind to neuropilin-2 with high projections of these neurons. The accessory OB, unlike the main OB, does not express high levels of semaIV,
affinity (Adams et al., 1997; Chen et al., 1997). It remains to be determined if neuropilin-2 is necessary and/or
and this lack of semaIV expression may serve to help segregate VNO projections to the accessory OB from sufficient to mediate the repulsive effects of Sema E or whether, in light of our demonstration that neuropilins OE projections to the main olfactory bulb. We and others (Chen et al., 1997) note that neuropilin-2 is strongly ex-1 and 2 can form heteromultimers when expressed in cultured cells, both neuropilins are required for this repressed by both VNO neurons and their target region in the accessory OB. It is possible that homophilic neusponse. In addition, since our studies have used the neuropilin-2(a)17 isoform, it will be of interest to learn ropilin-2 interactions may serve to help establish appropriate connectivity between the VNO and the accessory whether there are isoform-specific functional differences among the several neuropilin-2 splice variants olfactory bulb and may even function to regulate fasciculation of accessory olfactory neurons. semaIV is exidentified thus far. The neuropilin extracellular domains are complex, conpilin-2 is also expressed in commissural neurons and DRG sensory neurons at E11.5 in the mouse (Chen et sisting of two CUB domains, two coagulation factor domains, and one MAM domain. All three of these domains al., 1997), early semaIV expression may influence the ventral trajectories of these neurons as well. The formahave been implicated in mediating protein-protein interactions; however, it is essential to learn exactly how tion of sympathetic chain ganglia, which express both neuropilin-1 and neuropilin-2, also may be affected by they contribute to forming binding sites for secreted semaphorins, with the ultimate goal being to understand Sema IV in closely flanking mesenchymal tissue bordering the vertebral body and rib arches. Taken together, how neuropilins help transduce a repulsive steering signal to responsive neuronal growth cones. One important these semaIV and neuropilin-2 expression data strongly suggest that this receptor-ligand pair defines specific clue comes from our demonstration that the CUB and coagulation factor domains are the semaphorin ligandrepulsive axon guidance events in vivo. Also of interest is the similarity in the expression observed for neurobinding domains. Additional insight comes from experiments demonstrating that a chimeric neuropilin protein pilin-1 and semaIV, which includes coexpression in several neuronal tissues, including the dorsal horn of the consisting of the CUB and coagulation factor domains from neuropilin-2 fused to the MAM, transmembrane, spinal cord, DRG, the cortical plate, and the trigeminal ganglia (Kawakami et al., 1995: this study). Though Sema and cytoplasmic domains of neuropilin-1 confers a functional response to Sema IV in neurons growing from IV can bind to neuropilin-1 in vitro, this interaction does not lead to an alteration in neuronal guidance. It is possi-DRG explants in culture-neurons that normally do not express neuropilin-2 and are not responsive to Sema ble, however, that this interaction may serve to negatively regulate neuropilin-1 function and thereby render IV. Since Sema IV binds to both neuropilin-1 and neuropilin-2, these results suggest that Sema IV functional these populations of neurons less sensitive to Sema III during portions of their trajectories. specificity is the result of the distinct nature of its interactions with the CUB and coagulation factor domains of In the periphery, semaIV displays discrete and strong expression in numerous organ systems that receive the two neuropilins. Sema IV binding to the CUB and coagulation factor domains of neuropilin-2 results in sympathetic innervation, including the eye, salivary glands, skin, blood vessels, heart, lung, and the gastroreceptor activation and signal propagation, while its association with the analogous domains in neuropilin-1 intestinal and urogenital tract. Neurons in the superior cervical ganglion, postganglionic neurons in the sympadoes not result in receptor activation and signal propagation. semaIV is expressed in or around several populathetic chain, and distinct peripheral plexuses express neuropilin-2 mRNA ( and is joined via XhoI/SalI sites to the human Fc fragment. As a however, the 5Ј-300 bp are non-semaIV sequences resulting from negative control, we generated a construct in which the AP moiety a cloning artifact. Antisense probes were generated with T3 RNA was directly fused to the Fc fragment. All ligand constructs used polymerase by linearizing the rat semaIV cDNA in the 5Ј-most portion for binding studies contain a C-terminal myc flag for characterization of the semaIV ORF with Age I (nucleotides 697-2995). Sense probes of the corresponding recombinant proteins. were synthesized with T3 RNA polymerase by using a PCR-amplified fragment, including nucleotides 527-2995 of rat semaIV cDNA. All probes for in situ analysis contained only semaIV sequences. CryoLigand Preparation sections (20 m) of E15 and E18 rat embryos were processed for AP-tagged ligands were produced in HEK 293T cells. DNA was in situ hybridization as described .
introduced into cells by Lipofectamine (GIBCO) or CaPO 4 coprecipitation. Conditioned medium was harvested 48 hr posttransfection Neuropilin and Semaphorin Ligand Constructs and concentrated in Centri-prep 30 devices (Amicon). Ligand conneuropilin-1 deletion constructs for ligand-binding assays were crecentration was determined as described (Flanagan and Leder, 1990 ) ated by inverse PCR using the ExSite kit (Stratagene). Full length assuming a specific activity of 2000 U/mg. VEGF was obtained from Npn-1 in the expression vector pMT21 served as a template for PCR Sigma, and [ 125 I]VEGF was obtained from Amersham. reactions using oligo pairs that flanked the CUB (a1/a2), coagulation factor (b1/b2), and MAM (c) domains. The oligonucleotides contained a Sal I restriction site at their 5Ј ends and were designed Binding Assays Npn-1 full length and deletion constructs were expressed in COS such that upon annealing, the 3Ј end of the oligos were directed away from each other. Following amplification, inverse PCR prodcells following transfection by Lipofectamine. Forty-eight hours posttransfection, cells were washed with PBS and incubated with ucts were digested with Sal I and circularized by ligation yielding Npn-1 mutant constructs: Npn-1⌬a (T30-F258), Npn-1⌬b (S283-ligand for 1 hr at room temperature. Cells were washed six times with HBHA (Cheng and Flanagan, 1994) and lysed in 10 mM Tris M578), Npn-1⌬c (G647-C809), Npn-1⌬ab (T30-M578), and Npn-1⌬bc (S283-C809). In the cases of Npn-1⌬a, Npn-1⌬c, and Npn-1⌬bc, the and 1% Triton X-100 (pH 8.0). Triton X-100 insoluble proteins were removed by centrifugation at 10,000 ϫ g. AP activity present in the deleted amino acids were replaced with VE encoded by the Sal I restriction site. In the cases of Npn-1⌬b and Npn-1⌬ab, the deleted soluble fraction was determined by a soluble AP assay (Flanagan and Leder, 1990) . To control for differences in the amount of cellular amino acids were replaced with VEQVE. To generate the Npn-1⌬ac construct, a pair of c domain-flanking oligos were utilized in conmaterial in each lysate, bound AP activity was normalized by the amount of total soluble protein in the lysate, as determined by a junction with Npn-1⌬a template to perform inverse PCR, after which the product was blunt end ligated. The deleted c domain (G647-bicinchoninic acid (BCA) protein assay (Pierce). To control for differences in the expression of various deletion constructs on the surface E834) was replaced by VEQ. All cloning sites were sequenced, and the expression of correctly sized Npn-1 mutants was confirmed by of the cells, the relative surface expression of Npn-1 was determined. Cells transfected in parallel with those used for the ligandimmunoblotting.
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